ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM)

CUSIP: G6333L101

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Stock
Total 13F shares
6,552,309
Share change
+381,164
Total reported value
$2,566,448
Price per share
$0.39
Number of holders
33
Value change
+$47,246
Number of buys
11
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP G6333L101?
CUSIP G6333L101 identifies ITRM - ITERUM THERAPEUTICS PLC SHS NEW - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) as of Q4 2021

As of 31 Dec 2021, ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,552,309 shares. The largest 10 holders included Canaan Partners X LLC, New Leaf Venture Partners, L.L.C., Anson Funds Management LP, Virtu Financial LLC, FRANKLIN RESOURCES INC, MORGAN STANLEY, GRIMES & COMPANY, INC., JANE STREET GROUP, LLC, RENAISSANCE TECHNOLOGIES LLC, and Verition Fund Management LLC. This page lists 33 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.